RankingsPricing
  1. US-listed companies
  2. INSMED Inc
  3. Financials
  4. Common stock and paid-in capital

INSMED IncINSM

Market cap
$41.3B
P/E ratio
SummaryFinancials
Period EndCommon stock and paid-in capital (Million USD)YoY (%)
Dec 31, 20244,648+49.20%
Dec 31, 20233,115+11.90%
Dec 31, 20222,784+4.08%
Dec 31, 20212,675+26.99%
Dec 31, 20202,106+17.13%
Dec 31, 20191,798+20.65%
Dec 31, 20181,490+13.00%
Dec 31, 20171,319+43.40%
Dec 31, 2016920+2.12%
Dec 31, 2015901+37.08%
Dec 31, 2014657+22.82%
Dec 31, 2013535+17.41%
Dec 31, 2012456+6.46%
Dec 31, 2011428

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)